Mereo BioPharma (MREO) Cash from Operations (2023 - 2026)
Mereo BioPharma (MREO) posted quarterly Cash from Operations of 4312000.0 for Q1 2026, up 48.23% year-on-year from 2909010.85 in Q1 2025, and up 43.87% on a QoQ basis from 7682000.0 in Q4 2025.
Mereo BioPharma (MREO) Cash from Operations (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has reported Cash from Operations for 4 consecutive years, with 4312000.0 the latest figure, recorded in Q1 2026.
- Quarterly Cash from Operations rose 48.23% year-over-year to 4312000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 26954000.0 (up 18.74% YoY) and the FY2025 annual result came in at 30971000.0, up 5.67% from the prior year.
- Cash from Operations grew to 4312000.0 in Q1 2026 per MREO's latest filing, from 7682000.0 in the prior quarter.
- Over the last five years, Cash from Operations for MREO reached as high as 2659000.0 in Q3 2023 and fell as low as 9420000.0 in Q4 2024.
- A 4-year average of 6865307.69 and a median of 7682000.0 in 2025 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2024 — Cash from Operations plunged 382.78% — and 2026, when it jumped 48.23%.
- Year by year, Cash from Operations stood at 6789000.0 in 2023, then sank by 38.75% to 9420000.0 in 2024, then climbed by 18.45% to 7682000.0 in 2025, then jumped by 43.87% to 4312000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 4312000.0, 7682000.0, and 7309000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Mereo BioPharma | 232.52 Mn | 232.52 Mn | - | -4.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.31 Mn |
| Mar 31, 2026 | -4.31 Mn |
| Dec 31, 2025 | -7.68 Mn |
| Dec 31, 2025 | -7.68 Mn |
| Sep 30, 2025 | -7.31 Mn |
| Sep 30, 2025 | -7.31 Mn |
| Jun 30, 2025 | -7.65 Mn |
| Jun 30, 2025 | -7.65 Mn |
| Mar 31, 2025 | -8.33 Mn |
| Mar 31, 2025 | -8.33 Mn |
| Dec 31, 2024 | -9.42 Mn |
| Dec 31, 2024 | -9.42 Mn |
| Sep 30, 2024 | -7.52 Mn |
| Sep 30, 2024 | -7.52 Mn |
| Jun 30, 2024 | -7.90 Mn |
| Jun 30, 2024 | -7.90 Mn |
| Mar 31, 2024 | -7.99 Mn |
| Mar 31, 2024 | -7.99 Mn |
| Dec 31, 2023 | -6.79 Mn |
| Dec 31, 2023 | -6.79 Mn |